SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddys Lab reports Profit after tax of Rs 4810.00 Mln, in the September 2020 quarter

28 Oct 2020 Evaluate
Revenue reduced marginally to stand at Rs. 33458.00 millions during the quarter ended September 2020. The figure stood at Rs. 34460.00 millions during the year-ago period.A big decline of -64.76% was reported for the quarter ended September 2020 to Rs. 4810.00  millions from Rs. 13651.00 millions of corresponding previous quarter.A decline of 8432.00 millions was observed in the OP in the quarter ended September 2020 from 12375.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202009 201909 % Var 202009 201909 % Var 202003 201903 % Var
Sales 33458.00 34460.00 -2.91 65902.00 59547.00 10.67 118504.00 106255.00 11.53
Other Income 266.00 767.00 -65.32 6713.00 5481.00 22.48 7432.00 2384.00 211.74
PBIDT 8432.00 12375.00 -31.86 24166.00 21396.00 12.95 36128.00 25381.00 42.34
Interest 93.00 122.00 -23.77 233.00 243.00 -4.12 478.00 568.00 -15.85
PBDT 8339.00 12253.00 -31.94 23933.00 21153.00 13.14 35650.00 24813.00 43.67
Depreciation 2142.00 2041.00 4.95 4119.00 4011.00 2.69 7892.00 7806.00 1.10
PBT 6197.00 10212.00 -39.32 19814.00 17142.00 15.59 27758.00 17007.00 63.22
TAX 1387.00 -3439.00 -140.33 5502.00 -1990.00 -376.48 -1619.00 4234.00 -138.24
Deferred Tax 273.00 -4968.00 -105.50 1997.00 -5047.00 -139.57 -6458.00 1416.00 -556.07
PAT 4810.00 13651.00 -64.76 14312.00 19132.00 -25.19 29377.00 12773.00 129.99
Equity 831.00 831.00 0.00 831.00 831.00 0.00 831.00 830.00 0.12
PBIDTM(%) 25.20 35.91 -29.82 36.67 35.93 2.05 30.49 23.89 27.63

Dr. Reddys Labs. Share Price

1345.30 -11.55 (-0.85%)
01-Jul-2026 11:29 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1873.35
Dr. Reddys Labs. 1345.30
Cipla 1452.65
Zydus Lifesciences 1111.15
Lupin 2397.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: